Researchers discover and characterize a novel membraneless organelle that could play a role in Alzheimer's treatment
Kenneth S. Kosik
-
-
Researchers survey the landscape of rare mutations behind neurodegenerative diseases in Colombia -
Neuroscientist Kenneth Kosik to receive 2021 Potamkin Prize for his Alzheimer’s research -
A woman who defied a genetic mutation that guarantees early-onset Alzheimer’s donates her brain to research -
Surveillance study reveals how COVID-19 can travel silently through a community via asymptomatic carriers -
Researchers and medical staff collaborate to detect asymptomatic cases of COVID-19 on campus -
Scientists develop a faster, less expensive COVID-19 test that can be deployed in the field -
Understanding how the protein tau moves between neurons yields insight into possible treatments for neurodegenerative diseases -
A woman’s resistance to genetic, early-onset Alzheimer’s may hold the key to future therapies for the neurodegenerative disease -
Pluripotency is a feature of stem cell populations in which individual cells must know a great deal about their surroundings -
A ‘druggable’ mechanism of tau protein pathology could lead to new treatment for dementia -
Another early-onset Alzheimer’s gene mutation is found in a Colombian family, and is traced back to Africa
-
Knowledge about the interactions of messenger RNAs and micro-RNAs during brain development helps to identify neurological cell types -
UCSB neuroscientist Kenneth Kosik examines the importance of basic cell biology research -
The documentary “Can Alzheimer’s be Stopped?” screens at UCSB’s Pollock Theater, followed by a panel discussion -
Multiple drug development efforts for treating Alzheimer’s would operate simultaneously
